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ABSTRACT
DS (Down syndrome), resulting from trisomy of chro-
mosome 21, is the most common cause of genetic mental
retardation; however, the molecular mechanisms under-
lying the cognitive deficits are poorly understood. Growing
data indicate that changes in abundance or type of CSPGs
(chondroitin sulfate proteoglycans) in the ECM (extra-
cellular matrix) can influence synaptic structure and
plasticity. The purpose of this study was to identify changes
in synaptic structure in the hippocampus in a model of DS,
the Ts65Dn mouse, and to determine the relationship to
proteoglycan abundance and/or cleavage and cognitive
disability. We measured synaptic proteins by ELISA and
changes in lectican expression and processing in the
hippocampus of young and old Ts65Dn mice and LMCs
(littermate controls). In young (5 months old) Ts65Dn
hippocampal extracts, we found a significant increase in the
postsynaptic protein PSD-95 (postsynaptic density 95)
compared with LMCs. In aged (20 months old) Ts65Dn
hippocampus, this increase was localized to hippocampal
stratum oriens extracts compared with LMCs. Aged Ts65Dn
mice exhibited impaired hippocampal-dependent spatial
learning and memory in the RAWM (radial-arm water maze)
and a marked increase in levels of the lectican versican V2 in
stratum oriens that correlated with the number of errors
made in the final RAWM block. Ts65Dn stratum oriens PNNs
(perineuronal nets), an extension of the ECM enveloping
mostly inhibitory interneurons, were dispersed over a larger
area compared with LMC mice. Taken together, these data
suggest a possible association with alterations in the ECM
and inhibitory neurotransmission in the Ts65Dn hippocam-
pus which could contribute to cognitive deficits.
Key words: chondroitin sulfate proteoglycan, Down
syndrome, extracellular matrix, stratum oriens, Ts65Dn,
versican.
INTRODUCTION
DS (Down syndrome) results from trisomy of human
chromosome 21 and is the most common genetic cause of
mental retardation (Canfield et al., 2006). The neurological
phenotype of DS patients may range from severe cognitive
dysfunction to milder learning impairments (Epstein, 2002),
and nearly all DS subjects exhibit AD (Alzheimer’s disease)
pathology by the fourth decade of life (Burger and Vogel,
1973). The detailed molecular mechanism(s) that lead(s) to
cognitive deficits either in young or older DS subjects is
poorly understood. Studies have demonstrated changes in
synaptic structure in key cognitive brain regions, including
the hippocampus, and suggest that these contribute to
mental retardation (Belichenko et al., 2004, 2007; Popov
et al., 2011).
The most widely used research model of DS, the Ts65Dn
mouse (Davisson et al., 1990; Reeves et al., 1995) takes
advantage of synteny between a large portion of mouse
chromosome 16 and human chromosome 21. A segment of
mouse chromosome 16 is translocated on to chromosome 17
which results in triplication of about half the genes that are
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asnneuro.org / Volume 4 (1) / art:e00073 11triplicated in DS (Olson et al., 2004). Neurologically, in the
Ts65Dn hippocampus, there are abnormally sized presynaptic
terminals, enlarged dendritic spines, altered inhibitory and
excitatory circuitry (Belichenko et al., 2004, 2007, 2009b),
deficits in LTP (long-term potentiation) (Siarey et al., 1997,
1999; Kleschevnikov et al., 2004), and reduced hippocampal-
dependent learning and memory (Demas et al., 1996, 1998;
Escorihuela et al., 1998; Hyde et al., 2001; Hunter et al.,
2003). A region of human chromosome 21 termed the DSCR
(Down syndrome critical region) is triplicated in Ts65Dn, and
this region has been hypothesized to be sufficient to cause
the DS phenotype. In fact, a mouse model with triplication of
just the DSCR genes exhibited a neurobiological phenotype
characteristic of DS (Belichenko et al., 2009a). Recent gene
expression studies have revealed a chromosome 21 gene, Adamts1
(a disintegrin and metalloproteinase with thrombospondin
motifs-1), was up-regulated 3.7-fold in DS prefrontal cortex
(46-76 years old) when compared with control brains, well
beyond the predicted 1.5-fold increase expected due to gene
dosage (Lockstone et al., 2007). Interestingly, no change in
Adamts1 expression was seen in fetal DS brain, suggesting an
age-related effect. Adamts5, another chromosome 21 gene, is
also triplicated in DS. Studies with human DS subjects have
shown an age-related decline of cognitive function (Thase
et al., 1984) perhaps implicating an age-related dysregulation
of Adamts1 that could be involved in the cognitive deficits.
ADAMTS1 is one of several members of the secreted ADAMTS
metalloproteinase family capable of cleaving the core protein
of a small subset of CSPGs (chondroitin sulfate proteoglycans),
termed lecticans (Jones and Riley, 2005; Porter et al., 2005).
Lecticans are a major component of the ECM (extracellular
matrix) in the CNS (central nervous system) (Yamaguchi, 2000;
Rauch, 2007) that, together with hyaluronic acid and smaller
glycoproteins, form an aggregate lattice in the extracellular
space. This aggregate encompasses neurons as PNNs (perineur-
onal nets) (Bruckner et al., 1993) and also surrounds synapses.
Functionally, CSPGs have been shown to be inhibitory towards
neurite outgrowth (Galtrey and Fawcett, 2007; Zimmermann
and Dours-Zimmermann, 2008). Data from our laboratory
indicated that cleavage of the lecticans by the ADAMTSs
loosens the ECM aggregate and promotes a more neuroplastic
microenvironment. Indeed, we have shown that the ADAMTSs
enhanceneuriteoutgrowthinvitro(Hameletal.,2008)andare
selectively active in brain regions showing terminal sprouting
in models of plasticity (Yuan et al., 2002; Mayer et al., 2005).
Thus, increased ADAMTS1 in the Ts65Dn brain could lead to
dysfunctional alterations in the ECM. Altered cleavage of
lecticans, however, may not be the only contributor to the
structural and functional deficits. A change in the deposition
of the matrix component reelin, for example, was shown to be
involved in the loss of cognitive processes in the aged Ts65Dn
hippocampus (Kern et al., 2011). This finding suggests that
there may also be changes in the abundance of matrix
molecules such as the lecticans that could affect neuronal
structure as well as cognition. The accumulation of reelin (and
tau in the extracellular space) was seen in aged Ts65Dn mice
and has also been noted to occur to a greater extent in
untreated aged mice (Kuo et al., 1996; Mitsuno et al., 1999).
Since changes in the ECM aggregate can affect synapse
maintenance and development and since marked overexpres-
sion of Adamts1 was seen in adult DS prefrontal cortex, the
aim of this study was to determine whether alterations
in processing of lecticans in brain ECM due to abnormal
expression of ADAMTS1 in the Ts65Dn mouse was associated
with changes in synaptic abundance. Our studies examined
both adult (5 months old) and aged (20 months old) mice
for several reasons. The loss of basal forebrain cholinergic
neurons, the major cholinergic input to the hippocampus,
occurs after 5 months of age (Cooper et al., 2001) and has
been postulated to be involved with cognitive deficits in DS
patients and the Ts65Dn mouse (Isacson et al., 2002). Basal
forebrain cholinergic neurons continue to degenerate with
aging (Holtzman et al., 1996; Cooper et al., 2001), and several
studies have shown that cognitive deficits become more
severe with aging in DS patients (Thase et al., 1984; Nelson
et al., 2005) and in the Ts65Dn mouse (Holtzman et al., 1996;
Kurt et al., 2000; Salehi et al., 2009). Given the increased
expression of Adamts1 in aged DS patients and an increase in
extracellular granules seen in aged Ts65Dn mice, it is possible
that changes in ECM processing and abundance could become
more apparent in the aged mouse.
WehavedevelopedseveralELISAstomeasureproteinmarkers
of synapses (Gottschall et al., 2010), and these markers are
thought to reflect the abundance of synapses. There are con-
flictingreports in the literature as towhether synaptic proteins
are altered in the brain of Ts65Dn mice. Synaptophysin was
reported to be significantly decreased in adult Ts65Dn
hippocampus (Pollonini et al., 2008), yet synaptophysin levels
were unchanged in whole brain synaptosomal preparations
(Fernandez et al., 2009). However, these synaptic marker levels
in these studies were measured by immunoblot which is less
quantitative than ELISA. In this study, ELISA measurement of
synaptic marker proteins was used to examine whether there
arechangesin synapticabundance inTs65Dnbrainregionsand
whether they are associated with ADAMTS1-derived changes
in lectican processing.
MATERIALS AND METHODS
Animals
All animal protocols were approved by the Institutional
Animal Care and Use Committee at the University of Arkansas
for Medical Sciences and every effort was made to limit the
number of animals required for these experiments. Male
Ts65Dn and LMC (littermate control) mice were purchased
from the Jackson Laboratory (stock 001924). Mice were
housed individually under standard laboratory conditions
with access to food and water ad libitum. Mice were aged
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All behavioural testing was performed during the light phase
of the 12 h light/12 h dark cycle. Seven LMC and eight
Ts65Dn mice at five months of age and 11 LMC and
nine Ts65Dn mice at 20 months of age were subjects in these
experiments.
RAWM (radial-arm water maze)
To examine spatial cue recognition learning and memory
in LMC and Ts65Dn mice, we utilized a modified version of
the RAWM (Alamed et al., 2006). Twenty-month-old Ts65Dn
(n59) and LMC (n511) mice were randomly assigned a
number and divided into two separate cohorts that were
tested at different times. All mice were housed separately and
the experimenter was blinded to the genotype. The RAWM
consisted of a wading pool (89 cm wide and 19 cm high)
spray painted black with a metal insert (84 cm wide and
14 cm high) that divided the pool into six equal lanes. Each
mouse was randomly assigned a goal arm where the platform
was placed for every trial. The start arm was randomly chosen
and varied for each mouse for each trial. Spatial cues were
simple geometric shapes (triangle, diamond and rectangle)
that were clipped around the pool and remained in the same
spot for all trials. The experimenter was also a visual cue and
remained in the same spot for all trials for all mice. The water
in the pool was maintained at 20˚C.
On day 1 the mice were trained on the RAWM. Two groups
of six mice separately received 12 trials. For the first trial, a
mouse was released from the start arm and had 60 s to find
a visible platform in the goal arm. An error was considered
as either an entry into an arm without the platform or 15 s
without entering an arm or remaining in an incorrect arm. If
the mouse did not locate the platform after 60 s it was gently
guided to it; all mice remained on the platform for 10 s. For
the second trial, the platform was switched to hidden (an all
black terracotta pot hidden 2 mm below the water surface)
but was otherwise identical with the first trial. The third trial
used the visible platform as in trial 1. The fourth to sixth
trials used the hidden platform. After six trials the first co-
hort rested under heat lamps while the second cohort
received trials 1–6 as described above. The first cohort then
received six additional trials with only the hidden platform and
this protocol was repeated for the second cohort. The mice
were tested again on day 2 to determine their ability to recall
the location of the platform based on the spatial cues. Day 2
testing proceeded as on day 1, except the hidden platform was
used for all trials. The mice were then tested 1 week later (day
9) following the same protocol as for day 2. The average
number of errors a mouse made over a block of three trials
(block 1 was trials one through three, block 2 was trials four
to six, etc.) was calculated and used for analysis. We excluded
four LMC mice from analysis due to lack of active learning
during the RAWM – they would avoid climbing on the plat-
form and continue swimming in the pool. When examining the
correlation with the Ts65Dn stratum oriens, one value was
excluded from analysis. This sample had high versican V2
abundance but a low number of errors for only the final block
of the RAWM.
Tissue preparation
Mice were killed with an overdose of carbon dioxide and the
brain removed from the skull. For some mice the brain was
cut sagitally and half was placed in 4% (w/v) PFA (para-
formaldehyde) overnight and then placed in PBS containing
0.04% sodium azide until processed further for immuno-
histochemistry. Cerebellum, brainstem, frontal cortex,
temporal cortex, hippocampus, rest of cortex and rest of
brain were dissected from the other half and stored at 280˚C
until use. For some brains, the cerebellum and frontal cortex
were removed and the remainder of the brain was flash
frozen in dry-ice cooled hexane (Sigma–Aldrich) for 15 s,
and then stored in a freezer at 280˚C for hippocampal
microdissection (see below).
Protein was extracted from brain regions using RIPA
buffer [50 mM Tris/HCl, 150 mM NaCl, 2 mM EDTA, 1% DOC
(sodium deoxycholate), 0.1% SDS and 1% Triton X-100] with
1:100 dilution of protease inhibitor cocktail III (Calbiochem).
The tissue and 10 vol. of RIPA buffer were homogenized in a
2 ml glass homogenization tube with Teflon-coated homo-
genizer (20 up-and-down motions). The homogenate was
transferred to a 1.5 ml microcentrifuge tube and centri-
fuged at 21100 g for 15 min at 4˚C. The supernatant was
removed from the pellet and the BCA (bicinchoninic acid)
proteinassay (Thermo-Pierce)was used todetermine the protein
concentration. Extracts were stored in aliquots at 280˚C.
Hippocampal microdissection
Frozen brains were mounted on cryostat chucks with OCT
(optimal cutting temperature) compound (Sakura Finetek
USA) on dry ice, equilibrated to 222˚C, and then sectioned
with a cryostat at 200 mm. Sections with dorsal hippocampus
(bregma 21.0 mm to bregma 22.3 mm, Figure 2A; Paxinos
and Franklin, 2001) were mounted on Superfrost/Plus glass
slides (Fisher Scientific) and a finger was placed underneath
the section so that it would melt to the slide. Two or three
sections were mounted on each slide and slides were stored at
280˚C until microdissection.
Slides with sections were placed on a Petri dish with ice
and observed under a Zeiss StemiDV4 stereoscope (Carl Zeiss
Microscopy and Imaging). The sections were thawed and the
stratum oriens, dentate gyrus and rest of hippocampus were
dissected (Figure 2B); four to seven sections were dissected
from each brain. The hippocampal subregions were sonicated
for 3 s with a sonic dismembrator at setting 2 (Model 100,
Fisher Scientific) in 40 ml of ice cold RIPA buffer containing
1:100 protease inhibitor cocktail III. The samples were then
centrifuged at 21100 g for 5 min at 4˚C to pellet any insoluble
material and protein was measured by the BCA method. The
supernatants were stored at 280˚C.
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13ELISA
Sandwich ELISAs for the presynaptic vesicular protein,
synaptophysin, the presynaptic membrane protein SNAP-25
(25 kDa synaptosome-associated protein), the postsynaptic
scaffolding protein PSD-95 (postsynaptic density 95), and
GFAP (glial fibrillary acidic protein) were performed as de-
scribed (Gottschall et al., 2010) with modifications to some
capture and detection antibodies and dilutions (Table 1). The
secondary antibody was goat anti-rabbit IgG conjugated
to HRP (horseradish peroxidase) (Millipore) diluted 1:1000
(synaptophysin and PSD-95) or 1:5000 (SNAP-25 and GFAP).
Supernatant from an RIPA homogenate of whole mouse brain
was used for constructing a standard curve with a selected
dilution (near beginning of saturation) designated as
100 units of binding activity (Gottschall et al., 2010). Levels
of markers measured in units were normalized by dividing the
units obtained in ELISA by the protein concentration for
the sample to obtain units of ELISA protein per mg of protein.
Immunoblotting
Sample extracts containing equal protein amounts (5 mg
for glutamine synthetase, 15 mg for brevican and fragments,
and 30 mg for versican and fragments) were combined with
26Laemmli sample buffer, heated at 95˚C for 4 min, loaded
on to Tris/glycine 4–20% gradient SDS/PAGE gels (Invitrogen)
and electrophoresed. Proteins were electorphoretically trans-
ferred to PVDF (Immobilon, Millipore) and probed for various
antigens. Membranes were washed in buffer B (16PBS and
0.05% Tween-20, pH 7.4) for 5 min and then blocked in
buffer B containing 5% (w/v) non-fat dried skimmed milk
powder (SaCo) for 1 h. Table 1 lists the primary antibodies
and dilutions used; the antibodies referring to amino acid
sequences are neoepitope metalloproteinase cleavage se-
quences in either brevican or versican (Mayer et al., 2005;
Ajmo et al., 2010). Blots were then incubated with goat
anti-mouse IgG or goat anti-rabbit IgG conjugated to HRP
(Millipore) diluted 1:20,000. Antigens were visualized with
the Immobilon Western Chemiluminscent HRP Substrate
(Millipore) and the blots were exposed using a Kodak 4000 MM
imager (Carestream Health) or to autoradiography film (Denville
Scientific).
Quantification of immunoblots
The Kodak Molecular Imaging Software (Carestream Health)
was used to measure the mean intensity of each antigen band
as well as the background for each blot. For the glutamine
synthetase blots, the film was scanned at 400 dpi with the
Perfection V700 Photo scanner (Epson), converted into 8-bit
greyscale, the background subtracted, the colour inverted,
and the mean intensity for each band measured with ImageJ
software. For each method the background was subtracted
from each sample and this value was then divided by the
mean intensity for GAPDH (glyceraldehyde-3-phosphate
dehydrogenase) for the same blot to obtain normalized mean
intensity. For each antigen LMC and Ts65Dn normalized
mean intensity values were divided by the average mean
intensity for all LMC samples to obtain the percentage of LMC.
Immunohistochemistry
Each fixed hemibrain was sequentially cryoprotected in 15%
and 30% sucrose overnight at 4˚C, mounted on a cryostat
Figure 1 Synaptic protein measurement in LMC and Ts65Dn hippocampal extracts
The synaptic proteins SNAP-25 (A), synaptophysin (B), PSD-95 (C) and the astrocyte protein GFAP (D) were measured by ELISA in 5-
and 20-month-old LMC and Ts65Dn hippocampal extracts. At 5 months of age, n57 or 8 mice per genotype; at 20 months of age,
n56 mice for each genotype. For each ELISA, values for LMC and Ts65Dn hippocampus at the same age were compared with a
Student’s t test; *P,0.05, **P,0.01.
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sectioned at 30 mm with a Microm HM505 cryostat. Sections
were stored free floating in PBS at 4˚C until used in
immunohistochemistry.
Three sections per brain bearing dorsal hippocampus were
washed in PBS three times for 5 min each, blocked and
permeabilized in 10% normal goat serum, 3% 1 M lysine,
0.3% Triton X-100 for 1 h and then incubated overnight at
4˚C with biotinylated WFA (Wisteria floribunda agglutinin;
1:2000, Vector Laboratories) and rabbit anti-GFAP (1:2000,
Dako). The sections were then washed and incubated at
1:1000 with streptavidin–Alexa FluorH 488 and goat anti-
rabbit IgG–Alexa FluorH 568 (Millipore). Sections were
mounted on Superfrost/Plus glass slides with Vectashield
Figure 2 Synaptic protein measurement in LMC and Ts65Dn hippocampal region extracts
Hippocampal regions were microdissected from 200 mm hemibrain sections from 20 months old LMC and Ts65Dn mice between
Bregma 21.0 mm to Bregma 22.3 mm (A; black lines indicate the boundaries of the sections) and SO (stratum oriens, black outline),
DG (dentate gyrus, red outline) and remainder of the hippocampus (Rest of HC, blue outline) were microdissected (B). The synaptic
proteins SNAP-25 (C), synaptophysin (D), PSD-95 (E) and astrocyte protein GFAP (F) were measured by ELISA (n55 mice for each
genotype). For each ELISA, values for LMC and Ts65Dn subregions were compared with a Student’s t test; *P,0.05. Images from (A)
and (B) adapted from (Paxinos and Franklin, 2001).
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15Mounting Medium with DAPI (49,6-diamidino-2-phenylindole;
Vector Laboratories).
Image acquisition and analysis
Images were acquired with an Olympus BX51 microscope
using a 620 PlanApo lens (Olympus Inc.) and Metamorph
software (Molecular Devices) using the same gain and
intensity. TIFF files were exported for analysis with ImageJ
software. The polygon tool was used to draw a boundary
around each PNN, and mean intensity and area were
measured (at least 30 PNNs per mouse). The mean intensity
was divided by area for each PNN and the quartiles
determined. Each net was assigned a category as follows: 1
(,25th percentile), 2 (.25th percentile and ,50th percent-
ile), 3 (.50th percentile and ,75th percentile) and 4 (.75th
percentile). This same procedure was followed to categorize
PNNs based on area. The experimenter was blinded to the
genotype during image acquisition and analysis.
RNA isolation and qRT–PCR (quantitative reverse
transcription–PCR)
Total RNA was isolated from 5 months old LMC and Ts65Dn
whole hippocampus using the RNeasy Lipid Tissue Mini Kit
(Qiagen). Total RNA concentration was determined with the
NanoDrop ND-1000 Spectrophotometer (Thermo Scientific)
and 1 mg of total RNA was reverse-transcribed with the High
Capacity cDNA Reverse Transcription Kit (Applied Biosystems).
qRT–PCR was performed using the ABI7900HT Fast Real-Time
PCR System with TaqMan Gene Expression Master Mix and
TaqMan Gene Expression Assays (Applied Biosystems) for the
following genes: Adamts1 (Assay ID Mm00477355_m1),
Adamts4 (Assay ID Mm00556068_m1), Adamts5 (Assay ID
Mm00478620_m1) and Gapdh (Assay ID Mm03302249_g1).
Samples were assayed in triplicate and the average loga-
rithmic Ct (threshold cycle) value was converted into the
linear form using the conversion 2
2Ct (Nairn et al., 2007). For
each sample, linear Ct values for the Adamts genes were
divided by the linear Ct Gapdh value to obtain relative
transcript abundance.
Statistics
Statistical analysis was performed with GraphPad Prism 5
(GraphPad Software). Data from RAWM were analysed with a
repeated measures of ANOVA with Bonferroni pairwise
comparison. We further compared the average number of
errors made during each block by one-way ANOVA for each
genotype followed by Bonferroni’s multiple comparison test.
ELISA, densitometry and relative transcript abundance data
were analysed with Student’s t test (two-tailed); PNN
categorical data were analysed with the Cochran–Armitage
test for trend; and values for PNN mean intensity/area
and area were analysed with the Mann–Whitney U test. For
all tests, P,0.05 was considered a significant difference. All
values are shown as means¡S.E.M.
RESULTS
Measurement of synaptic proteins by ELISA
Our laboratory developed ELISAs for SNAP-25, synaptophysin
and PSD-95 (Gottschall et al., 2010) and we used these to
measure relative synaptic abundance in hippocampal extracts
from LMC and Ts65Dn mice. We found no significant differ-
ence in the levels of the presynaptic markers SNAP-25 or
synaptophysin at either 5 or 20 months of age in Ts65Dn
whole hippocampus (Figures 1A and 1B) compared with LMC.
However, a significant 19% increase in PSD-95 was observed
at 5 but not 20 months of age in the Ts65Dn hippocampus
(Figure 1C), although there was a trend for an increase at
20 months. Levels of the astrocyte intermediate filament
GFAP were also measured and we found a 44% decrease at
5 months of age and a 35% decrease at 20 months of age in
whole hippocampus compared with LMC extracts (Figure 1D).
We saw no difference in the levels of these proteins in the
frontal cortex and cerebellum at either 5 (Supplementary
Figure S1 available at http://www.asnneuro.org/an/004/
an004e073add.htm) or 20 months of age (Supplementary
Table 1 Antibodies used for ELISA and immunoblotting
Application Antibody Source Dilution
ELISA capture Mouse anti-SNAP-25 Millipore 1:200
Mouse anti-synaptophysin Millipore 1:200
Mouse anti-PSD-95 NeuroMab 1:250
Mouse anti-GFAP Millipore 1:250
ELISA detection Rabbit anti-SNAP-25 Sigma–Aldrich 1:1000
Rabbit anti-synaptophysin Santa Cruz 1:1000
Rabbit anti-PSD-95 Millipore 4 mg/ml
Rabbit anti-GFAP Dako 1:1000
Western Blotting Mouse anti-brevican BD Biosciences 1:1000
Rabbit anti-EAMESE Gottschall Laboratory, Mayer et al. (2005) 1:1000
Rabbit anti-SAHPSA Ajmo et al. (2010) 1:500
Mouse anti-versican V2 (12C5) DSHB 1:1000
Rabbit anti-NIVNSE Gottschall Laboratory 1:500
Mouse anti-glutamine synthetase Millipore 1:5000
Rabbit anti-GAPDH Cell Signalling 1:5000
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an004e073add.htm) in the Ts65Dn mouse compared with
LMC extracts.
Only a minimal difference in synapse abundance was
observed in whole Ts65Dn hippocampal extracts; however,
there may be regional, localized changes in synaptic markers
that are masked by a variable baseline when assaying whole
tissue extract. Thus, levels of synaptic markers were measured
in microdissected hippocampus including stratum oriens,
dentate gyrus and remainder of hippocampus (Figure 2B). We
found a 24% increase in PSD-95 in Ts65Dn stratum oriens
compared with LMCs (Figure 2E) with no changes in SNAP-25
and synaptophysin in any of the Ts65Dn hippocampal
subregions compared with their LMCs (Figures 2C and 2D).
The decrease in GFAP seen in the Ts65Dn whole hippocampal
extract was markedly observed in the Ts65Dn dentate gyrus
(Figure 2F), with a 37% decline compared with LMC dentate
gyrus. To determine whether the decrease in GFAP in Ts65Dn
whole hippocampus and hippocampal regions was consistent
with another astrocyte-specific protein, we examined the
level of glutamine synthesis by Western blotting, a protein
involved in both GABA (c-aminobutyric acid) and glutamate
neurotransmission. At either 5 or 20 months old whole
hippocampus and in hippocampal regions there was no
difference in glutamine synthetase levels between Ts65Dn
and LMC extracts (data not shown).
Spatial learning and memory in aged Ts65Dn and
LMC mice
We next wanted to determine whether the decrease in PSD-95
abundance was associated with alteration in hippocampal-
dependent, spatially mediated learning and memory by
subjecting the 20-month-old mice to platform seeking in the
RAWM (Alamed et al., 2006). Mice were tested over 3 days: day
1 was learning of the platform location, day 2 was recall and
day 9 tested long-term recall of the platform location. Both
Ts65Dn and LMC mice committed approximately five errors for
the first block of three trials on day 1 (Figure 3). The LMC mice
appeared to learn the location of the platform more quickly
than Ts65Dn mice as they averaged 1.0 error on the last block
(block4)ofday1,whiletheTs65Dnmiceaveraged 3.5errors.On
the second day of testing, the LMC mice averaged 1.9 errors for
b l o c k5 ,w h i l et h eT s 6 5 D nm i c ea v e r a g e d4 . 3e r r o r s( F i g u r e3 ) .
The Ts65Dnmice continuedtocommitmore errors than the LMC
mice over all trials on day 2 ending with 2.8 errors compared
with 0.9 errors for LMC mice. This same trend was apparent on
day 9; the LMC mice committed well less than 1 error over all
four blocks, while the Ts65Dn mice reached a plateau at
2.5 errors per block (Figure 3). We found a significant genotype
effect by repeated-measures ANOVA [F(1,14)512.07,
P50.0041] as well as a significant difference between LMC
a n dT s 6 5 D nm i c ef o rb l o c k s3a n d9b yB o n f e r r o n ip a i r w i s e
comparison. Further, by block 3 and for all remaining blocks, the
LMC mice made significantly fewer errors than during block 1
(Figure 3). However, there were no significant differences
between the errors made in block 1 and all other blocks for the
Ts65Dn mice. These results suggest that aged Ts65Dn mice
exhibit impaired spatial learning and memory.
Lectican abundance and processing in the
Ts65Dn and LMC hippocampus
Lecticans are essential components of the ECM in the CNS
andarethought toregulatestructural andfunctional plasticity
of synapses especially during critical periods late during
development (Pizzorusso et al., 2002). Since the lectican-
cleaving metalloproteinases, ADAMTS1 and ADAMTS5 are
approximately 2-fold overexpressed in the Ts65Dn hippocam-
pus (Supplementary Figure S3 available at http://www.
asnneuro.org/an/004/an004e073add.htm), we hypothesized
that there would be excess processing of lecticans in Ts65Dn
brain that may relate to changes in synapse abundance.
The abundance and ADAMTS processing of two prominent
lecticans (brevican and versican) in the hippocampus were
measured. Brevican content and processing were unchanged
in 5 and 20 months old Ts65Dn whole hippocampus or in
any of the 20 months old hippocampal subregions (data not
shown). However, the abundance of versican V2, 245 kDa
holoprotein, was increased significantly at both 5 months
(56%) and 20 months (224%) of age in Ts65Dn hippocampus
(Figure 4), but there was no change in the level of the
ADAMTS-derived proteolytic fragment NIVNSE (50 kDa). In
hippocampal subregions, there was a marked 250% increase
in versican V2 abundance in the Ts65Dn stratum oriens
compared with LMC. While there was also a trend towards
an increase in both the dentate gyrus and rest of hippo-
campus (89%) this was not a statistically significant
difference (Figure 5).
Figure 3 RAWM performance in aged LMC and Ts65Dn mice
20-month-old LMC and Ts65Dn mice (n57 or 8 mice per genotype) received
12 RAWM trials (four blocks of three trials) for each day tested. Data were
analysed with a two-way repeated measures ANOVA and Bonferroni pairwise
comparison; *P,0.05 for Ts65Dn compared with LMC at the same time point.
For each genotype, errors for blocks 2–12 were compared with errors from
block 1 with a one-way ANOVA with Bonferroni pairwise comparison test;
ˆ
P,0.01.
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17Correlation between versican V2 abundance and
RAWM performance
Since spatial memory as measured in the RAWM is mediated
by the hippocampus, and the presence of lecticans is
important in synaptic plasticity (Frischknecht et al., 2009),
we wanted to examine whether there was a correlation
between altered abundance of versican V2 and performance
in the RAWM. There was a correlation between increased
versican and an increase in the number of errors in the final
block (block 12) of the RAWM in the Ts65Dn stratum oriens
(P50.0044, r
250.9912), but not LMC stratum oriens
(Figure 6A). Further,therewasnocorrelation between versican
abundance and errors in the final block of the RAWM in
the Ts65Dn or LMC dentate gyrus or rest of hippocampus
(Figures 6B and 6C).
PNNs in stratum oriens
The increase in versican V2 in stratum oriens could be
attributed to alterations in PNNs, of which versican V2 has
been shown to be a component (Carulli et al., 2006; Deepa
et al., 2006). PNNs were visualized with WFA, a lectin that
binds to N-acetylgalactosamine residues (Figures 7A and 7B),
and PNNs were categorized based on the mean intensity per
area (category 1–4, with 1 being the lowest values). There
were more Ts65Dn PNNs in category 1 and fewer in cate-
gory 4 compared with LMCs (Figure 7C; x
253.922, df51,
P50.0476) and an overall 21% decline in mean intensity/area
(Figure 7D). This decrease could be due to an increase in PNN
area so PNNs were also classified by area into categories as
above. There was a greater number of Ts65Dn PNNs of the
highest area (category 4) and lower number in the smallest
area (category 1) compared with LMCs (Figure 7E; x
257.265,
df51, P50.0070). Indeed, Ts65Dn PNNs exhibited a 24%
increase in area compared with LMCs (Figure 7F). These data
suggest that Ts65Dn stratum oriens PNNs encompass a larger
neuronal surface than seen with LMC PNNs.
DISCUSSION
Decreased numbers of presynaptic and postsynaptic terminals
were previously observed during development in Ts65Dn
stratum oriens (Chakrabarti et al., 2007) and Ts65Dn dentate
gyrus has been shown to have a reduced number of neurons
(Insausti et al., 1998) and deficient LTP (Kleschevnikov et al.,
Figure 4 Versican V2 abundance and processing in LMC and Ts65Dn hippocampal extracts
Immunoblots of hippocampal extracts from mice at 5 months of age, n57 mice per genotype; and mice at 20 months of age, n56
mice per genotype. NIVNSE refers to the ADAMTS-derived N-terminal fragment of versican V2. Mean densitometric values were
normalized to GAPDH (data not shown) and then expressed as a percentage of LMC. For each age, values for LMC and Ts65Dn
hippocampus were compared with a Student’s t test; *P,0.05.
Figure 5 Versican V2 abundance in LMC and Ts65Dn hippocampal region
extracts
Immunoblots from 20-month-old LMC and Ts65Dn hippocampal regions
(n55 mice for each genotype). The mean versican V2 densitometric value for
each sample was normalized to GAPDH (data not shown) and then expressed
as a percentage of LMC. For each hippocampal region, the LMC and Ts65Dn
values were compared with a Student’s t-test; *P,0.05.
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that aged Ts65Dn mice exhibit an increase in levels of PSD-95,
PNNs that encompass greater neuronal surface areas and
a marked increase in levels of versican V2 in hippocampal
stratum oriens. With this microdissection technique, we were
able to measure synaptic markers and ECM proteins and found
localized changes that may be masked when measured in
wholebraintissue.Further,thereappearedtobeanassociation
between the localized, increased levels of ECM and learning
and memory deficits in the Ts65Dn mouse.
While it is known that trisomy of human chromosome
21 leads to DS, the exact genes and molecular mechanism(s)
underlying the cognitive impairment are poorly understood.
Initially, we tested whether overexpression of the gene
Adamts1, encoding a metalloproteinase that cleaves lecticans
in the ECM of the CNS, and capable of altering neural plas-
ticity, may be involved in the pathophysiology of mental
retardation in DS. Our data with the Ts65Dn mouse, however,
suggest that this is not the case. While we found a 2-fold up-
regulation in Adamts1 in the Ts65Dn hippocampus, this
change was not as robust as that seen in adult DS brains,
and we found no changes in the ADAMTS-specific cleavage
fragments of the lecticans brevican and versican. However,
intact versican V2 holoprotein was found to be significantly
elevated in the Ts65Dn hippocampus, a finding that could
implicate changes in the ECM as associated with the cognitive
deficit in the Ts65Dn mouse.
Versican occurs as three isoforms in the brain (V0–V2), with
V2 the primary isoform found in adult brain (Milev et al.,
1998). V2 has been shown to inhibit neurite outgrowth
whether bearing CS chains or not (Schmalfeldt et al., 2000).
Versican V2 abundance was increased in Ts65Dn hippocampus
and stratum oriens with a trend towards an increase in dentate
gyrus and remainder of the hippocampus. Further, we found a
significant positive correlation between versican V2 in Ts65Dn
stratum oriens and the number of errors made in the final
block of the RAWM. We found a range in the abundance of
versican V2 immunoreactivity in Ts65Dn mice that was not
observed with brevican. This variability is directly associated
with synaptic marker abundance in stratum oriens, suggesting
it may be associated with the cognitive deficit in Ts65Dn mice.
We found a significant increase in PSD-95 at 5 months
(19%) but not at 20 months of age in Ts65Dn whole hippo-
campus. However, there was a significant 24% increase in
Ts65Dn stratum oriens at 20 months of age. Previous studies
that have measured synaptic proteins in the Ts65Dn brain
have yielded conflicting results. Using synaptosomes from
whole cortex of Ts65Dn mice, one study showed no change in
multiple synaptic markers (Fernandez et al., 2009). Since the
changes observed here were localized to stratum oriens,
these changes may have been masked in previous studies that
examined large brain regions. Another study that measured
synaptophysin in stratum oriens found increased levels in
Ts65Dn mice at 6 months of age, but these levels were not
different at 16 months of age (Belichenko et al., 2004). Since
we found no changes in presynaptic synaptic protein levels, it
may be that there is no change in the number of synapses in
this region, but rather an increase in the synapse size.
Stratum oriens contains multiple populations of inhibitory
interneurons and an age-related loss of GAD67-positive
inhibitory interneurons has been observed in rats (Stanley
et al., 2012). This same age-dependent decrease in inter-
neurons may not occur in Ts65Dn stratum oriens. One study
showed pharamacological antagonism of GABAA receptors
rescued the LTP deficit in Ts65Dn mice which suggests either
increasedGABA-mediatedinhibitionoranincreaseinplasticity
Figure 6 Correlation analysis between versican V2 in hippocampal region
extracts and RAWM performance for LMC and Ts65Dn mice
Correlation between versican V2 immunoreactivity and the number of errors
committed in the final block (block 12) of the RAWM for stratum oriens (A),
dentate gyrus (B), and rest of hippocampus (C). Linear regression analysis was
performed to determine the significance of the r
2 value (see the text).
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19atGABAergicsynapses(Costa and Grybko,2005). Anti-Hebbian
LTP or LTP that occurs when presynaptic firing is paired with
postsynaptic hyperpolarization, has been reported at excit-
atory boutons that synapse on inhibitory interneurons in the
stratum oriens (Lamsa et al., 2007). The excitatory synapses of
Ts65Dn stratum oriens interneurons could undergo this
plasticity to a greater extent than in LMC mice to promote a
stronger, larger synapse. Indeed, local changes in protein
synthesis, including PSD-95, serve to stabilize potentiated
synapses (Ostroff et al., 2002). This change would increase
excitation of the inhibitory interneurons and stimulate
inhibitory neurotransmission in the hippocampus. This plas-
ticity may occur early in development, denoted by the increase
in PSD-95 observed at 5 months with the stronger synapses
maintained throughout aging.
The strengthened interneurons in Ts65Dn stratum oriens
could be maintained by the increased versican V2 which may
represent an increase in PNNs. PNNs have been observed in
stratum oriens (Mayer et al., 2005) and versican can be a
component of PNNs, although the exact lectican composition
of PNNs is not known. PNN formation can also be activity
dependent (Zaremba et al., 1989; Dityatev et al., 2007),
so stronger excitation of the interneurons may result in in-
creased PNN formation and/or increased versican V2 in
existing PNNs surrounding inhibitory interneurons. Indeed,
our data indicate increased PNN surface area on neurites
in Ts65Dn stratum oriens which could stabilize inhibitory
interneurons and presumably increase inhibitory output
leading to deficient spatial learning and memory.
The decrease in GFAP in both 5- and 20-month-old Ts65Dn
hippocampus could indicate a decrease in the number or
reactivity of astrocytes. Studies have reported increased S-
100 immunoreactive cells throughout development and aging
in DS temporal cortex (Griffin et al., 1989) and also an
increase in S-100-positive cells in the DS hippocampus from
gestation to old age (Mito and Becker, 1993), but also no
difference in S-100 cell distribution in DS brain (Michetti
et al., 1990). Interestingly, expression of Gfap was found to
be significantly lower in the neocortex of DS patients
(Goodison et al., 1993). Additionally, modest increases in
GFAP immunoreactive astrocytes (Holtzman et al., 1996)
and GFAP by immunoblotting (Contestabile et al., 2006) have
Figure 7 PNNs in LMC and Ts65Dn stratum oriens
Representative images of WFA-positive PNNs in LMC (A) and Ts65Dn (B) SO (stratum oriens) and SP (stratum pyramidale). Individual
PNNs were measured and the mean intensity and area determined (n5141 LMC PNNs and n5125 Ts65Dn PNNs). PNNs were then
categorized based on their mean intensity per area (C). Note that category 1 indicates the lowest mean intensity/area. Mean
intensity/area values for measured PNNs were also compared (D). PNNs were also categorized by area (E; category 1 is smallest area)
and the values for area of PNNs was compared (F). (C) and (E) were analysed with Cochran–Armitage test for trend (see the text for
details). *P,0.05 and **P,0.01 by Mann–Whitney U test. (A, B) Scale bar: 100 mm.
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GFAP decrease was localized to the Ts65Dn dentate gyrus,
an area that has been associated with deficient LTP
(Kleschevnikov et al., 2004). A recent study demonstrated
that astrocytic gliosis (accompanied with an increased in
GFAP) was associated with a decrease in neuronal inhibition
(Ortinski et al., 2010). Decreased inhibition was related to a
decrease in glutamine synthetase, the enzyme that converts
glutamate to glutamine and ultimately to GABA in inhibitory
terminals. Glutamine synthetase activity was shown to be
elevated in 19-month-old Ts65Dn hippocampus which would
support an increase in inhibition (Contestabile et al., 2006).
While we found no difference in glutamine synthetase be-
tween LMC and Ts65Dn hippocampus, it is possible there is a
change in activity beyond protein levels. Thus, it is possible
that a decrease in GFAP may indeed be associated with
an increase in neuronal inhibition which would support the
decrease in LTP in the Ts65Dn dentate gyrus.
In summary, we have found that aged Ts65Dn mice exhibit
deficient hippocampal-dependent spatial learning and mem-
ory accompanied by a modest increase in PSD-95 and a
marked increase in versican V2 in hippocampal stratum
oriens. Further, the increase in versican V2 correlated with
increased number of errors in the RAWM, a measure of spatial
learning and memory. These molecular changes in the com-
position of the ECM may functionally influence the cognitive
deficit in the Ts65Dn mouse and in DS patients.
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